Par Drugs and Chemicals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021
For the six months, sales was INR 360.78 million compared to INR 282.67 million a year ago. Revenue was INR 361.43 million compared to INR 283.22 million a year ago. Net income was INR 46.76 million compared to INR 51.11 million a year ago. Basic earnings per share from continuing operations was INR 3.8 compared to INR 4.155 a year ago. Diluted earnings per share from continuing operations was INR 3.8 compared to INR 4.155 a year ago.